Start with its own history
At 61.40×, SYNH is 18.2% above its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
61.40×
18.2% abovethe 7-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 61.40 for every 1 of reported earnings per share.
Annual period-end data · 9 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2022 | 14.27× | -68.6% |
| Dec 31, 2021 | 45.43× | +23.4% |
| Dec 31, 2020 | 36.83× | -21.4% |
| Dec 31, 2019 | 46.83× | -72.6% |
| Dec 31, 2018 | 171.09× | N/M |
| Dec 31, 2017 | N/M | N/M |
| Dec 31, 2016 | 25.29× | +5.3% |
| Dec 31, 2015 | 24.01× | N/M |
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2014 | N/M | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
SYNH This stockSyneos Health, Inc. | 61.40× |
ALPNAlpine Immune Sciences, Inc. | N/M |
NARIInari Medical, Inc. | N/M |
LHCGLHC Group, Inc. | 86.20× |
OPTOpthea Limited | N/M |
MRTXMirati Therapeutics, Inc. | N/M |
OLKOlink Holding AB (publ) | N/M |
AMEDAmedisys, Inc. | 76.51× |
CBAYCymaBay Therapeutics, Inc. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 61.40×, SYNH is 18.2% above its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 2 positive peer ratios above is 81.35×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("SYNH", "PE Ratio", "LQ")Share price 42.98 ÷ EPS 0.7 = 61.40×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.